Search Results 191-200 of 32234 for Ovarian

1. A First-in-Human Study Of MEN2501 In Participants With Platinum-Resistant Ovarian Cancer - Mayo Clinic

   A First-in-Human Study Of MEN2501 In Participants With Platinum-Resistant Ovarian Cancer · Overview · Participation eligibility · Participating Mayo Clinic ...

2. Ovarian cysts - Doctors and departments - Mayo Clinic

   Many women have ovarian cysts at some time. Most are harmless, but some can cause serious symptoms. Know what symptoms to watch for.

3. Sean C. Dowdy, M.D. - Mayo Clinic Faculty Profiles

   Dowdy studies the genetic changes in ovarian cancer that predict improved response to treatment and identifies new treatment options for both ovarian and ...

4. Ovary removal may increase risk of chronic kidney disease - Mayo Clinic News Network

   — Premenopausal women who have their ovaries surgically removed face an increased risk of developing chronic kidney disease, according to a Mayo Clinic study ...

5. Investigating Surgery for Women at High Risk of Breast and Ovarian Cancer - Mayo Clinic News Network

   BRCA1 carriers face an average cumulative risk of 67 percent for breast cancer and 45 percent for ovarian cancer by age 80. For BRCA2 carriers, those average ...

6. Telomere Length Comparison of Diminished and Normal Ovarian Reserve - Mayo Clinic

   About this study. The purpose of this study is to determine if women with diminished ovarian reserve have shortened telomere lengths compared to women with ...

7. Amanika Kumar, M.D. - Doctors and Medical Staff - Mayo Clinic

   Ovarian/fallopian tube/peritoneal cancer; Endometrial/uterine cancer; Ovarian cysts and masses; Pelvic masses; Cervical cancer; Vulvar cancer; Vaginal cancer ...

8. A Study to Collect Ovarian Tissue from Girls Undergoing Fertility-preserving Cryopreservation - Mayo Clinic

   The purpose of this study is to study the handling of ovarian tissue, cryopreservation technology, and oocyte maturation for female pediatric cancer patients ...

9. Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

   Cediranib maleate may stop the growth of ovarian, fallopian tube, or primary peritoneal cancer by blocking the growth of new blood vessels necessary for tumor ...

10. A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression - Mayo Clinic

    ... Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression. Print ... ovarian epithelial carcinoma. CA125 response is defined as ≥ 50% decrease ...